| Patient‐Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement PI Spuls, LAA Gerbens, E Simpson, CJ Apfelbacher, JR Chalmers, ... British Journal of Dermatology 176 (4), 979-984, 2017 | 171 | 2017 |
| European guideline (EuroGuiDerm) on atopic eczema: part I–systemic therapy A Wollenberg, M Kinberger, B Arents, N Aszodi, G Avila Valle, S Barbarot, ... Journal of the European Academy of Dermatology and Venereology 36 (9), 1409-1431, 2022 | 166 | 2022 |
| Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative) JR Chalmers, E Simpson, CJ Apfelbacher, KS Thomas, L Von Kobyletzki, ... British Journal of Dermatology 175 (1), 69-79, 2016 | 144 | 2016 |
| European guideline (EuroGuiDerm) on atopic eczema–part II: non‐systemic treatments and treatment recommendations for special AE patient populations A Wollenberg, M Kinberger, B Arents, N Aszodi, G Avila Valle, S Barbarot, ... Journal of the European Academy of Dermatology and Venereology 36 (11), 1904 …, 2022 | 117 | 2022 |
| Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review LAA Gerbens, CAC Prinsen, JR Chalmers, AM Drucker, ... Allergy 72 (1), 146-163, 2017 | 91* | 2017 |
| Effectiveness of dupilumab treatment in 95 patients with atopic dermatitis: daily practice data LEM De Wijs, AL Bosma, NS Erler, LM Hollestein, LAA Gerbens, ... British Journal of Dermatology 182 (2), 418-426, 2020 | 83 | 2020 |
| Recommended core outcome instruments for health‐related quality of life, long‐term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting KS Thomas, CA Apfelbacher, JR Chalmers, E Simpson, PI Spuls, ... British Journal of Dermatology 185 (1), 139-146, 2021 | 82 | 2021 |
| Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative) JR Chalmers, KS Thomas, C Apfelbacher, HC Williams, CA Prinsen, ... British Journal of Dermatology 178 (5), e332-e341, 2018 | 78 | 2018 |
| Methotrexate and azathioprine for severe atopic dermatitis: a 5‐year follow‐up study of a randomized controlled trial LAA Gerbens, SAS Hamann, MWD Brouwer, E Roekevisch, ... British Journal of Dermatology 178 (6), 1288-1296, 2018 | 68 | 2018 |
| The HOME Core outcome set for clinical trials of atopic dermatitis HC Williams, J Schmitt, KS Thomas, PI Spuls, EL Simpson, ... Journal of Allergy and Clinical Immunology 149 (6), 1899-1911, 2022 | 64 | 2022 |
| Navigating the landscape of core outcome set development in dermatology CAC Prinsen, PI Spuls, J Kottner, KS Thomas, C Apfelbacher, ... Journal of the American Academy of Dermatology 81 (1), 297-305, 2019 | 56 | 2019 |
| Reporting of symptoms in randomized controlled trials of atopic eczema treatments: a systematic review LAA Gerbens, JR Chalmers, NK Rogers, H Nankervis, PI Spuls, ... British Journal of Dermatology 175 (4), 678-686, 2016 | 47* | 2016 |
| Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry AL Bosma, LEM de Wijs, MH Hof, BR van Nieuwenhuizen, LAA Gerbens, ... Journal of the American Academy of Dermatology 83 (5), 1375-1384, 2020 | 44 | 2020 |
| The International Treatment of Atopic Eczema (TREAT) Registry Taskforce: an initiative to harmonize data collection across national atopic eczema photo-and systemic therapy … PI Spuls, LAA Gerbens, CJ Apfelbacher, D Wall, BWM Arents, S Barbarot, ... The Journal of Investigative Dermatology 137 (9), 2014-2016, 2017 | 35 | 2017 |
| Phototherapy for atopic eczema AH Musters, S Mashayekhi, J Harvey, E Axon, SJ Lax, C Flohr, ... Cochrane Database of Systematic Reviews, 2021 | 34 | 2021 |
| TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic … LAA Gerbens, AE Boyce, D Wall, S Barbarot, RJ de Booij, M Deleuran, ... Trials 18, 1-12, 2017 | 33 | 2017 |
| TREatment of ATopic eczema (TREAT) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo‐and … LAA Gerbens, CJ Apfelbacher, AD Irvine, S Barbarot, RJ de Booij, ... British Journal of Dermatology 180 (4), 790-801, 2019 | 31 | 2019 |
| Which dressing do donor site wounds need?: study protocol for a randomized controlled trial AM Eskes, FE Brölmann, LAA Gerbens, DT Ubbink, H Vermeulen, ... Trials 12, 1-6, 2011 | 31 | 2011 |
| Measuring atopic eczema symptoms in clinical practice: the first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiative YA Leshem, JR Chalmers, C Apfelbacher, M Furue, LAA Gerbens, ... Journal of the American Academy of Dermatology 82 (5), 1181-1186, 2020 | 30 | 2020 |
| TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries FM Vermeulen, LAA Gerbens, AL Bosma, CJ Apfelbacher, AD Irvine, ... British Journal of Dermatology 181 (3), 492-504, 2019 | 30 | 2019 |
